Tags: Chemical Compound, Chemical Substance.

Ranirestat (AS-3201) is an aldose reductase inhibitor being developed for the treatment of diabetic neuropathy by Dainippon Sumitomo Pharma and PharmaKyorin. It has been granted orphan drug status. The drug is to be used orally.

Ranirestat_stereo.png
FDA UNII code
Z26P56GFTV
IUPAC name
(3R)-2'-(4-bromo-2-fluorobenzyl)-1H2H5H-spiro[pyrrolidine-34'-pyrrolo[12-a]pyrazine]-1'23'5(2H)-tetrone

Loading...

This page contains content from the copyrighted Wikipedia article "Ranirestat"; that content is used under the GNU Free Documentation License (GFDL). You may redistribute it, verbatim or modified, providing that you comply with the terms of the GFDL.